Dim Flicker: An Endogenous Visual Percept and Its Disease Associations
Abstract
1. Introduction
2. Methods
3. Results
3.1. Case 1
3.2. Case 2
3.3. Case 3
3.4. Case 4
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Sharpe, C.R. The visibility and fading of thin lines visualized by their controlled movement across the retina. J. Physiol. 1972, 222, 113–134. [Google Scholar] [CrossRef] [PubMed]
- Tehovnik, E.J.; Slocum, W.M.; Carvey, C.E.; Schiller, P.H. Phosphene induction and the generation of saccadic eye movements by striate cortex. J. Neurophysiol. 2005, 93, 1–19. [Google Scholar] [CrossRef] [PubMed]
- Nixon, T.R.W.; Davie, R.L.; Snead, M.P. Posterior vitreous detachment and retinal tear—A prospective study of community referrals. Eye 2024, 38, 786–791. [Google Scholar] [CrossRef] [PubMed]
- Gishti, O.; van den Nieuwenhof, R.; Verhoekx, J.; van Overdam, K. Symptoms related to posterior vitreous detachment and the risk of developing retinal tears: A systematic review. Acta Ophthalmol. 2019, 97, 347–352. [Google Scholar] [CrossRef] [PubMed]
- Kanski, J.J. Complications of acute posterior vitreous detachment. Am. J. Ophthalmol. 1975, 80, 44–46. [Google Scholar] [CrossRef] [PubMed]
- Nüßle, S.; Reinhard, T.; Lübke, J. Acute closed-angle glaucoma. Dtsch. Arztebl. Int. 2021, 118, 771–780. [Google Scholar] [CrossRef] [PubMed]
- Thomsen, A.V.; Ashina, H.; Al-Khazali, H.M.; Rose, K.; Christensen, R.H.; Amin, F.M.; Ashina, M. Clinical features of migraine with aura: A REFORM study. J. Headache Pain 2024, 25, 22. [Google Scholar] [CrossRef] [PubMed]
- Viana, M.; Hougaard, A.; Tronvik, E.; Winnberg, I.G.; Ambrosini, A.; Perrotta, A.; Do, T.P.; Al-Karagholi, M.A.-M.; Fominykh, M.; Sihabdeen, S.; et al. Visual migraine aura iconography: A multicentre, cross-sectional study of individuals with migraine with aura. Cephalalgia 2024, 44, 3331024241234809. [Google Scholar] [CrossRef] [PubMed]
- Schankin, C.J.; Viana, M.; Goadsby, P.J. Persistent and Repetitive Visual Disturbances in Migraine: A Review. Headache 2017, 57, 1–16. [Google Scholar] [CrossRef] [PubMed]
- Shah, D.R.; Dilwali, S.; Friedman, D.I. Current Aura Without Headache. Curr. Pain. Headache Rep. 2018, 22, 77. [Google Scholar] [CrossRef] [PubMed]
- Frohman, T.C.; Davis, S.L.; Beh, S.; Greenberg, B.M.; Remington, G.; Frohman, E.M. Uhthoff’s phenomena in MS--clinical features and pathophysiology. Nat. Rev. Neurol. 2013, 9, 535–540. [Google Scholar] [CrossRef] [PubMed]
- Hill, D.L.; Daroff, R.B.; Ducros, A.; Newman, N.J.; Biousse, V. Most Cases Labeled as “Retinal Migraine” Are Not Migraine. J. Neuro-Ophthalmol. 2007, 27, 3–8. [Google Scholar] [CrossRef] [PubMed]
- Olesen, J. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018, 38, 1–211. [Google Scholar] [CrossRef] [PubMed]
- Hadjikhani, N.; Sanchez Del Rio, M.; Wu, O.; Schwartz, D.; Bakker, D.; Fischl, B.; Kwong, K.K.; Cutrer, F.M.; Rosen, B.R.; Tootell, R.B.H.; et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc. Natl. Acad. Sci. USA 2001, 98, 4687–4692. [Google Scholar] [CrossRef] [PubMed]
- Carroll, D. Retinal migraine. Headache J. Head Face Pain 1970, 10, 9–13. [Google Scholar] [CrossRef] [PubMed]
- Evans, I.D.; Palmisano, S.; Croft, R.J. Retinal and Cortical Contributions to Phosphenes During Transcranial Electrical Current Stimulation. Bioelectromagnetics 2021, 42, 146–158. [Google Scholar] [CrossRef] [PubMed]
- Doyle, E.; Vote, B.J.; Cosswell, A.G. Retinal migraine: Caught in the act. Br. J. Ophthalmol. 2004, 88, 301–302. [Google Scholar] [CrossRef] [PubMed]

| Patient 1 | Patient 2 | Patient 3 | Patient 4 | |
|---|---|---|---|---|
| Age, sex | 48 y, male | 52 y, female | 69, female | 46 y, male |
| Visual field location of flicker | Periphery of inferior quadrants, right eye | Upper visual field, waves in motion, mostly right eye, in left eye never after PDT for CSC | Left eye, straight ahead, | Inferior quadrants, right eye |
| Best-corrected visual acuity OD/OS | 1.25/1.25 | 1.0/1.0 | 0.9/0.4 | 1.0/1.0 |
| Flicker rate [Hz] | 7 | 7 | 3 | 10 |
| Pattern | Oblique grating | Oblique ripples | Grating | Uniform patch |
| Visibility | Faint but distinct | Faint but distinct | Distinct | Faint but distinct |
| Transparency | High | High | High | High |
| Duration | Minutes | Minutes | Days | Minutes |
| Timing | Spontaneous, episodically, approx. 10 times per year | Spontaneous, up to hours | Left eye suddenly dark, after 1 h, finger counting but no colors, after 2 days near-normal colors, no flicker | Spontaneously, during and after jogging, after lying down |
| Ambient luminosity | Dim nocturnal after awakening and standing | Dim nocturnal and sometimes in daylight | Any | Any |
| Stimulating factors | After waking from sleep and while exercising | After strenuous exercise and in dim light | During event with retinal vein occlusion | Onset of flicker while jogging and exacerbation of events during episodes of retinal venous congestion |
| Alleviating factors | Ambient light | Ambient light | Faded after regression of retinal vein occlusion. | Faded with spontaneous regression of venous congestion. |
| Automated perimetry, OD/OS, mean deviation (−2,2) | 1.1 dB/−0.5 dB (normal) | 2.0 dB/4.0 dB (inferior to the fovea) | 7.2 dB/2.7 dB (nasal quadrants) | 3.4 dB/1.9 dB (irregular) |
| Medications | Metoprolol, losartan, apixaban, amlodipine | Dabigatran, formoterol | Pravastatin, levothyroxine, salbutamol, fluticasone | None |
| Past medical history | Atrial fibrillation, arterial hypertension, migraine with cortical and retinal visual aura | CSC OU with cessation of flicker OS after PDT, persisting OD. Pulmonary embolism. Occasional visual aura without migraine, non-scintillating, no flicker | Central retinal vein congestion with branch retinal artery hypoperfusion, cataract OU, hypercholesterolemia, hypothyroidism, asthma | CRVO OD, earlier hemi-CRVO OS. Left-side ophthalmic nerve herpes zoster, anterior uveitis |
| A. At least two attacks fulfilling criteria B and C |
| B. One or more of the following fully reversible aura symptoms: |
| 1. Visual. 2. Sensory. 3. Speech and/or language. 4. Motor. 5. Brainstem. 6. Retinal. |
| C. At least three of the following six characteristics: |
| 1. At least one aura symptom spreads gradually over ≥5 min |
| 2. Two or more aura symptoms occur in succession |
| 3. Each individual aura symptom lasts 5–60 min |
| 4. At least one aura symptom is unilateral * |
| 5. At least one aura symptom is positive (scintillations or pins and needles **) |
| 6. The aura is accompanied, or followed within 60 min, by headache |
| D. Not better accounted for by another ICHD-3 diagnosis and transitory ischemic attack has been excluded |
| Description: Repeated attacks of monocular visual disturbance, including scintillations, scotomata, or blindness, associated with migraine headache. |
| Diagnostic criteria: |
| A. Attacks fulfilling criteria for migraine with aura (see above) and criterion B below: |
| B. Aura characterized by both of the following: |
| 1. Fully reversible, monocular, positive and/or negative visual phenomena (e.g., scintillations, scotomata or blindness) confirmed during an attack by either or both of the following: |
| a. Clinical visual field examination. |
| b. The patient’s drawing of a monocular field defect (made after clear instruction). |
| 2. At least two of the following: |
| a. Spreading gradually over ≥5 min. |
| b. Symptoms last 5–60 min. |
| c. Accompanied or followed within 60 min by headache. |
| C. Not better accounted for by another ICHD-3 diagnosis and other causes of amaurosis fugax have been excluded. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Amini, A.; Besic, A.; Freund, A.; Subhi, Y.; Klefter, O.N.; Olesen, J.; Frederiksen, J.L.; Larsen, M. Dim Flicker: An Endogenous Visual Percept and Its Disease Associations. J. Clin. Med. 2026, 15, 622. https://doi.org/10.3390/jcm15020622
Amini A, Besic A, Freund A, Subhi Y, Klefter ON, Olesen J, Frederiksen JL, Larsen M. Dim Flicker: An Endogenous Visual Percept and Its Disease Associations. Journal of Clinical Medicine. 2026; 15(2):622. https://doi.org/10.3390/jcm15020622
Chicago/Turabian StyleAmini, Abdullah, Adam Besic, Avery Freund, Yousif Subhi, Oliver Niels Klefter, Jes Olesen, Jette Lautrup Frederiksen, and Michael Larsen. 2026. "Dim Flicker: An Endogenous Visual Percept and Its Disease Associations" Journal of Clinical Medicine 15, no. 2: 622. https://doi.org/10.3390/jcm15020622
APA StyleAmini, A., Besic, A., Freund, A., Subhi, Y., Klefter, O. N., Olesen, J., Frederiksen, J. L., & Larsen, M. (2026). Dim Flicker: An Endogenous Visual Percept and Its Disease Associations. Journal of Clinical Medicine, 15(2), 622. https://doi.org/10.3390/jcm15020622

